Switching from natalizumab to alemtuzumab in patients with relapsing multiple sclerosis.

Switching from natalizumab to alemtuzumab in patients with relapsing multiple sclerosis.

Publication date: May 11, 2019

John, N., Carroll, A., Brownlee, W.J., and Chataway, J. Switching from natalizumab to alemtuzumab in patients with relapsing multiple sclerosis. 17981. 2019 J Neurol Neurosurg Psychiatry.

Concepts Keywords
Alemtuzumab Organ systems
Multiple Sclerosis Chataway
Natalizumab Multiple sclerosis
Monoclonal antibodies
Immunosuppressants
Medical specialties
Alemtuzumab
Natalizumab
Immunology

Semantics

Type Source Name
disease DOID multiple sclerosis
disease MESH multiple sclerosis
drug DRUGBANK Alemtuzumab
drug DRUGBANK Natalizumab

Similar

Original Article

Leave a Comment

Your email address will not be published. Required fields are marked *